论文信息 - CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease. - 字舞流文

CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease.

K. Blennow | N. Seyfried | A. Mecca | Mary E. Hamby | Britney N. Lizama | Anthony O Caggiano | M. Grundman | Christopher H. van Dyck | Allan I. Levey | K. Pandey | C. Williams | D. Duong | V. Di Caro | H. Zetterberg | Hilary A North